Isosorbide Dinitrate

證據等級: L2 | 預測適應症: 10


## 藥師評估報告

Isosorbide Dinitrate:從 狹心症 到 肺高壓

一句話總結

Isosorbide dinitrate(二硝酸異山梨酯)是一種有機硝酸酯類血管擴張劑,用於預防和治療狹心症。TxGNN 模型預測它對**肺高壓 (pulmonary hypertension)** 有潛在治療效果,目前有超過 **20 篇文獻**支持此預測,證據等級高。

快速總覽

項目 內容
原適應症 預防及治療狹心症發作、冠狀動脈不全
預測新適應症 肺高壓 (pulmonary hypertension)、脫髮症 (alopecia)
TxGNN 預測分數 99.98% (肺高壓)
證據等級 L2
台灣上市 已上市
許可證數 多張
建議決策 Explore

預測適應症詳細分析

1. alopecia L5 99.99% 主要分析

為什麼這個預測合理?

Isosorbide dinitrate 通過釋放一氧化氮(NO)激活血管平滑肌細胞中的鳥苷酸環化酶,導致環磷酸鳥苷(cGMP)濃度升高,進而引起血管舒張。

</p>

此預測基於藥物的作用機轉,與現有臨床證據方向一致。

臨床試驗

目前無針對此特定適應症的臨床試驗登記。

</details>
2. congenital hypotrichosis milia L5 99.99%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
3. hypotrichosis simplex of the scalp L5 99.99%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
4. pulmonary hypertension L4 99.98%

相關文獻(20 篇)

PMID年份類型期刊主要發現
391645772025ArticleHeart and vesselsThe effects of bolus isosorbide dinitrate on pulmonary hypertension with cardiop...
64230151984ArticleBulletin europeen de physiopatNitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obst...
288106032017ArticleExperimental and therapeutic mIntratracheal administration of isosorbide dinitrate improves pulmonary artery p...
24981221989ArticleExperimental and molecular patComparative effects of isosorbide dinitrate, prednisolone, indomethacin, and ela...
3739401979ArticleClinical pharmacology and therEffects of isosorbide dinitrate on pulmonary hypertension in chronic obstructive...
293776912018ArticleJournal of medicinal chemistryIdentification of a Novel Hybridization from Isosorbide 5-Mononitrate and Bardox...
39257461985ArticleAmerican heart journalThe role of isosorbide dinitrate in the treatment of perioperative hypertension.
393987942024ArticleCureusBurden of Pulmonary Hypertension in End-Stage Renal Disease Patients Receiving M...
89082271996ArticleActa anaesthesiologica ScandinPulmonary vascular effects of nitroglycerin and isosorbide dinitrate in patients...
68615021983ArticleCritical care medicineTreatment of portal hypertension with isosorbide dinitrate alone and in combinat...
196205102009ArticleHypertension (Dallas, Tex. : 1Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and...
27324451989ArticleJournal of hepatologySystemic and regional hemodynamic effects of isosorbide dinitrate in patients wi...
71254071982ArticleAnnals of internal medicineVasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
34099161988ArticleEuropean heart journalLong-term reduction of pulmonary hypertension in interstitial lung fibrosis by i...
25210281989ArticleJournal of cardiothoracic anesThe effects of intravenous nitroglycerin and isosorbide dinitrate on hemodynamic...
33481401988ArticleThe American journal of cardioIntravenous isosorbide dinitrate during open-heart surgery and its role in the t...
69786911982ArticleThe Annals of thoracic surgeryIntravenous isosorbide dinitrate in the management of acute hypertension followi...
224235902011ArticleProceedings of the Western PhaTreatment with LA-419 prevents monocrotaline-induced pulmonary hypertension and ...
17430251991ArticleCor et vasaThe effect of acute and chronic nitrate administration in precapillary and postc...
31370651988ArticleEuropean heart journalControl of perioperative hypertension during coronary artery surgery. A randomis...
5. diffuse alopecia areata L5 99.98%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
6. vascular disease L1 99.97%

臨床試驗(49 項)

試驗編號階段狀態人數主要發現
NCT02045459NACOMPLETED79Assessment of Perfusion Reserve and Effects of Exercise in Microvascular Angina
NCT00803634PHASE3COMPLETED117A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A...
NCT03011775PHASE4COMPLETED43Effect of Pioglitazone on Insulin Resistance, Progression of Atherosclerosis and...
NCT01676207N/ACOMPLETED120Prevalence of Extracardiac Coronary Collateral Supply Via the Internal Mammary A...
NCT04317846NACOMPLETED165TransRadIal Evaluation STudy of diamEter Increase After Vasodilatory Drugs Admin...
NCT03451591PHASE2, PHASE3COMPLETED363LACunar Intervention (LACI-2) Trial-2: Assessment of Safety and Efficacy of Cilo...
NCT03255512PHASE1COMPLETED41Multi-center, Randomized, Placebo-controlled, Double-blind Group Comparison Stud...
NCT01631409N/AWITHDRAWN0Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave T...
NCT05082311N/ACOMPLETED55Prospective Cohort Study of Objective Cardiac and Vascular Changes in Pheochromo...
NCT02135315NACOMPLETED1500One-year Outcome of Intensive Versus Standard Blood Pressure Treatment in Non-ST...
NCT01430780N/AUNKNOWN68A Prospective Study to Evaluate the Influence of Oxygen Free Radical Injury Indu...
NCT01961453PHASE2WITHDRAWN0Targeting Wave Reflections to Improve Left Ventricular Hypertrophy, Fibrosis and...
NCT02627196NAUNKNOWN1200Barostim Neo® - Baroreflex Activation Therapy® for Heart Failure
NCT06715007N/ARECRUITING300Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel...
NCT00685945NACOMPLETED24Renin-Angiotensin Aldosterone System and Fibrinolysis(RAAS) Interaction in Human...
NCT01769079PHASE4COMPLETED95Withdrawal of Nitrate in Patients With Stable Angina - Multicenter Clinical Tria...
NCT02795910NAUNKNOWN40577Integrated Primary Care for Diabetes and Cardiovascular Disease in Less Develope...
NCT04661709PHASE4UNKNOWN502Efficacy and Safety of Chinese Herbal Medicine Wen Xin Granules for the Treatmen...
NCT03171480PHASE4COMPLETED176Randomized Controlled Trial of Nitric-oxide Donor (NOD) Isosorbide Mononitrate (...
NCT00808652N/ATERMINATED13Prevalence and Outcome of Brachial Artery Endothelial Function in Morbidly Obese...
NCT05954689NAUNKNOWN50Femoral Artery Block for Reduction of Tourniquet Induced Hypertension: a Randomi...
NCT00337116PHASE4WITHDRAWN80Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the ...
NCT01471834NAACTIVE_NOT_RECRUITING40Neo Non-Randomized Hypertension Study
NCT01130168PHASE1COMPLETED38A Double-Blind, Randomized, Placebo-Controlled, 3-Period, Crossover Study to Eva...
NCT02870985NACOMPLETED440BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in th...
NCT02305095N/ACOMPLETED225Genomic Analysis of the Enhanced Response to Heart Failure Therapy in African Am...
NCT02573051PHASE2WITHDRAWN0Misoprostol Plus Isosorbide Mononitrate Versus Misoprostol For Termination Of An...
NCT00143195PHASE4COMPLETED200Open Label Study Comparing Amlodipine vs Long-acting Nitrates in Patients With C...
NCT03072121PHASE4UNKNOWN440Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery D...
NCT01720160NAUNKNOWN98Barostim HOPE4HF Study
NCT00683696PHASE2, PHASE3TERMINATED1680Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
NCT02152579PHASE3UNKNOWN86Open Monocentric Clinical Study for the Evaluation of Efficacy and Safety of 20 ...
NCT02481323PHASE2COMPLETED57Preventing Cognitive Decline and Dementia From Cerebral Small Vessel Disease
NCT02011620PHASE4WITHDRAWN0Influence of Nitrates on Bone Remodeling and Endothelial Function in Patients Wi...
NCT00871871PHASE1COMPLETED64A Randomized, Double-Blind, Placebo-Controlled, 2-Part Study to Evaluate the Mul...
NCT00943852PHASE1COMPLETED13A Double-Blind, Randomized, Placebo-Controlled, 5-Period Crossover Study to Eval...
NCT04051957PHASE2TERMINATED9Isosorbide Mononitrate For Anti-Vascular Endothelial Growth Factor (VEGF) Induce...
NCT07252544PHASE3NOT_YET_RECRUITING3156Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Pa...
NCT02789033PHASE3COMPLETED68Efficacy of the Combination of Isosorbide Dinitrate Spray and Chitosan in Diabet...
NCT02228408PHASE4COMPLETED17A Phase IV Randomized, Double-blind, Active-controlled, Single-center Study of t...
NCT02522208PHASE1COMPLETED12Randomized, Open-Label, Daily Dose, 2-sequence, 2-way Crossover Pharmacodynamic ...
NCT01768182NACOMPLETED30Short-term Folinic Acid Supplementation Improves Vascular Reactivity in HIV-infe...
NCT01513070PHASE4COMPLETED120A Randomized Double-blind Placebo-controlled Clinical Trials of the Blood-quicke...
NCT00000478PHASE3COMPLETEDN/AAsymptomatic Cardiac Ischemia Pilot (ACIP) Study
NCT00810381NACOMPLETED14Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects
NCT05671250PHASE2COMPLETED30Novel Bioactive Smart Dressings for Diabetic Foot Ulcers: a Randomized Controlle...
NCT03072082PHASE4UNKNOWN440Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease ...
NCT04206865PHASE4WITHDRAWN0Prospective Comparison of ARNI to Alternate Oral Vasodilator Therapies to Determ...
NCT01270139NACOMPLETED180Plasmonic Photothermal Therapy of Flow-Limiting Atherosclerotic Lesions With Sil...

相關文獻(20 篇)

PMID年份類型期刊主要發現
99519541999ArticleDrugsLong-acting isosorbide mononitrate.
39257421985ArticleAmerican heart journalNitrate tolerance.
15760381992ArticleAACN clinical issues in criticNitrates.
21130031990ArticleEuropean journal of clinical pNitrates: why and how should they be used today? Current status of the clinical ...
78734661994ArticleCardiovascular drugs and theraClinical pharmacokinetics of nitrates.
64307671984ArticleHerzNitrate tolerance.
306874542018ArticleOxidative medicine and cellulaThe Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate ...
362195672023ArticleStroke and vascular neurologyCilostazol and isosorbide mononitrate for the prevention of progression of cereb...
8135101976ArticleThe American journal of cardioComparative effects of nitroglycerin and isosorbide dinitrate on coronary collat...
33252291987ArticleCurrent medical research and oIsosorbide-5-mononitrate and isosorbide dinitrate retard in the treatment of cor...
296829952018ArticleDiabetes & vascular disease reEfficacy and safety of the combination of isosorbide dinitrate spray and chitosa...
19690171990ArticleLancet (London, England)Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral va...
157580182005ArticleThe New England journal of medIsosorbide dinitrate and hydralazine in blacks with heart failure.
8050371975ArticleChestEffectiveness of isosorbide dinitrate and nitroglycerin in relieving angina pect...
3196621977ArticleThe American journal of mediciEffect of swallowed isosorbide dinitrate on blood pressure, heart rate and exerc...
27097441989ArticleKlinische WochenschriftPharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-...
38930781985ArticleAmerican heart journalHistory of the synthesis and pharmacology of isosorbide dinitrate.
10948191975ArticleAmerican heart journalComparative hemodynamic effects of placebo and oral isosorbide dinitrate in pati...
64230151984ArticleBulletin europeen de physiopatNitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obst...
73693071980ArticleAmerican journal of ophthalmolIsosorbide and isorbide dinitrate.
7. hypertrichosis (disease) L5 99.97%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
8. kyphoscoliotic heart disease L5 99.96%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
9. visceral calciphylaxis L5 99.96%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
10. arterial thoracic outlet syndrome L5 99.95%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
## 台灣上市資訊 | 許可證號 | 品名 | 劑型 | 核准適應症 | |---------|------|------|-----------| | 多張許可證 | 富利心舌下錠等 | 舌下錠/錠劑 | 預防狹心症發作、冠狀動脈不全、心絞痛 | ## 安全性考量 **常見副作用:** - 頭痛(最常見) - 頭暈 - 低血壓 - 臉部潮紅 - 心跳加速 **禁忌症:** - 與 PDE5 抑制劑(如 sildenafil)併用:可能導致嚴重低血壓 - 嚴重低血壓 - 右心室梗塞 - 肥厚性心肌病變伴流出道阻塞 **重要警告:** 肺高壓患者使用時可能導致全身性低血壓和心輸出量下降,需謹慎監測。 ### 藥物-疾病注意事項 (DDSI)
資料來源:DDInter 2.0(原文內容請參閱該網站)
**青光眼** 🔴 Major - 應謹慎使用本藥物。 **Cardiomyopathy, Hypertrophic** 🟡 Moderate - 注意事項:Organic nitrates and nitrites may aggravate the angina associated with hypertrophic cardiomyopathy and should be administered cautiously in patients w... **Myocardial Infarction** 🟢 Minor - 不應使用本藥物。需定期監測。風險包括:低血壓。 **Anemia** 🟢 Minor - 本藥物在此情況下禁用。風險包括:貧血。可能有嚴重不良反應。 **Diseases requiring hemodialysis** 🟢 Minor - 風險包括:低血壓。可能危及生命。 **低血壓** 🟢 Minor - 本藥物在此情況下禁用。需定期監測。風險包括:低血壓。可能有嚴重不良反應。 **Intracranial Hypertension** 🟢 Minor - 風險包括:出血。 ### 藥物-食物交互作用 (DFI)
資料來源:DDInter 2.0(原文內容請參閱該網站)
**酒精** 🟡 Moderate - 影響:產生協同作用。 - 建議:建議避免併用。需監測療效或不良反應。 ## 結論與下一步 **決策:Explore** **理由:** ISDN 對肺高壓的治療具有清晰的藥理機轉和豐富的文獻支持。多項研究顯示它能有效降低肺動脈壓力。然而,全身性血管擴張作用可能限制其在前毛細血管性肺高壓的應用。目前肺動脈高壓的標準治療已有更選擇性的藥物(如前列環素類似物、PDE5 抑制劑),ISDN 可能更適合作為輔助治療或特定亞群的替代選擇。 **若要推進需要:** - 明確 ISDN 在不同類型肺高壓中的定位 - 與現有標準治療的比較研究 - 確定最佳給藥途徑(吸入 vs 口服 vs 靜脈) - 長期安全性和耐受性數據 --- ## 相關藥物報告 - [Dronedarone](/drugs/dronedarone/) - 證據等級 L2 - [Hydroxyprogesterone Caproate](/drugs/hydroxyprogesterone_caproate/) - 證據等級 L2 - [Regorafenib](/drugs/regorafenib/) - 證據等級 L2 - [Hydroxyurea](/drugs/hydroxyurea/) - 證據等級 L2 - [Prednisone](/drugs/prednisone/) - 證據等級 L2 ---
用 AI 幫我深入分析

想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。

Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問

## 引用本報告 如需引用本報告,請使用以下格式: **APA 格式:** ``` TwTxGNN. (2026). Isosorbide Dinitrate老藥新用驗證報告. https://twtxgnn.yao.care/drugs/isosorbide_dinitrate/ ``` **BibTeX 格式:** ```bibtex @misc{twtxgnn_isosorbide_dinitrate, title = {Isosorbide Dinitrate老藥新用驗證報告}, author = {TwTxGNN Team}, year = {2026}, url = {https://twtxgnn.yao.care/drugs/isosorbide_dinitrate/} } ``` ---
免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。

最後審核:2026-02-20 | 審核者:TwTxGNN Research Team

討論與回饋

歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。


回到頂部

Copyright © 2026 Yao.Care. 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.